Clinical research mission fosters new discoveries in the novel therapies of Inflammatory Bowel Diseases, gastrointestinal and pancreatic cancer and hepatitis. Our doctors are committed to providing the best care and management of diseases while testing the very best in the cutting edge therapies.



     

For enrollment in our studies, contact the office of Clinical Research Program, or contact apropriate study coordinator for the recruiting studies listed below.

To view currently recruiting trials, please go to Clinical Research Trials at MGH.

Cancer

Andrew T. Chan, MD, MPH

  • Epidemiology of colorectal cancer
  • Chemoprevention of colorectal cancer
  • Novel techniques in detection of colorectal neoplasia
  • Epidemiology of gastrointestinal bleeding

Daniel Chung, MD

  • Adenoma prevention with celecoxib
  • Angiogenic profile of rectal cancer
  • Genetics and other causes of cancer
  • Sensitivity of the EXACT Panel in the detection of colorectal cancer

William Brugge

  • Staging of gastro-intestinal malignancies with endosonography
  • Endoscopic mucosal resection of early gastrointestinal malignancies
Esophagus

Norman Nishioka

  • Clinical trial to optimize aminolevulinic acid-based photodynamic therapy of Barrett's esophagus.

Chin Hur

  • Cost-effectiveness of the management of Barrett's esophagus +/- displasia: A Monte Carlo Markov model
IBD

Bruce Sands

  • A Six-Week Randomized, Double-Blind, Controlled Trial of Asacol 6.0 g/day versus Asacol 3.2 g/day for the Treatment of Mild to Moderate Crohn's Disease. (B. Sands) See Protocol Summary (Internal access only)
  • A Randomized Placebo-Controlled Trial of Rosiglitazone for Treatment of Ulcerative Colitis. (B. Sands) See Protocol Summary (Internal access only)
  • Development of a Steroid-Specific Quality of Life Instrument for Patients with Inflammatory Bowel Disease. (B. Sands) See Protocol Summary (Internal access only)
  • Identification of Susceptibility Genes in Inflammatory Bowel Disease.
  • A Double-Blinded, Randomized, Parallel Arm, Dose Ranging Study of IMURAN in Subjects with Active Crohn's Disease Requiring Treatment with Prednisone (ACORDIS).
  • Contact person: Stacey - 617-724-4301
Liver

Raymond Chung

  • A randomized, controlled trial of IFN-alfa + ribavirin vs. PEG-IFN-alfa + ribavirin in the treatment of HCV in HIV-coinfected patients
  • An analysis of risk factors for antiretroviral hepatotoxicity in HIV+ subjects
  • Viral evolution in persons with HCV and HIV receiving highly active antiretroviral therapy
  • A pilot study of postexposure prophylaxis in health care workers with occupational exposure to HCV
  • Insulin resistance in post liver transplant HCV disease (R. Chung)
  • A prospective study of insulin resistance in patients undergoing liver transplantation for HCV
  • Observational database on patients who receive orthotopic liver transplantation for hepatitis B
  • Clinical trial of lamivudine and perioperative IV hepatitis B imune globulin in the prevention of recurrent hepatitis B post-liver transplantation in low risk patients
  • Randomized trial of lamivudine and intramuscular hepatitis B immune globulin vs. lamivudine monotherapy as maintenance prophylaxis against recurrent hepatitis B post-liver transplantation in high risk patients
  • A multicenter study of acute liver failure
  • A multicenter study of intraveous N-acetyl cysteine in the treatment of non-acetominophen related acute liver failure
  • A phase I/II, double blind, dose escalation study to evaluate the safety, pharmacokinetics, and antiviral activity of val-mCyd (NM283) in adults with chronic Hepatitis C

Jules Dienstag

  • The hepatitis C antiviral long-term treatment against cirrhosis (HALT-C): A randomized, controlled trial to evaluate the safety and efficacy of long-term peginterferon alpha-2a for treatment of chronic hepatitis C in subjects who failed to respond to previous interferon therapy

Andrea Reid

  • Access of minorities with end-stage liver disease to orthotopic liver transplantation

Daniel Pratt, MD

  • Viral Hepatitis
  • Colorectal Liver Disease
Motility

Brad Kuo

  • A Phase III. Multicenter Open Label, Extension Study to Evaluate the Long Term Safety of Renzapride 4mg Once Daily in Women with Constipation-Predominant Irritable Bowel Syndrom
  • A Phase III, Multi-center, Randomized Double-Blind Placebo-Controlled Study of Renzapride in Women With constipation-Predominant Irritable Bowel Syndome
  • CNS Phenotype Characterization of Patients with NERD
  • A Phase II Study to Investigate the Safety and Efficacy of Dexloxiglumide for the Relief of Symptoms of Functional Dyspepsia
  • fMRI Expectation Analgesia and Acupuncture in IBS
  • GI Monitoring System with Gastric Emptying Determining Gastric Residence Time Using the Smartpill Capsule
  • Assesment of Whole Gut Transit Time Using the SmartPill Capsule
  • Nausea and Acupuncture (Sessions 1, 2 and 3)
  • Defining Central Circuits of Visceral Pain
Pancreas

William Brugge

  • Pancreatic cystadenomas: diagnosis and ablation with endosonography
  • Ethanol ablation of pancreatic cystadenoma
  • EUS guided injection of ethanol
Other

William Brugge

  • Evaluation and treatment of pancreatic pseudocysts
  • EUS-guided Portal Vein Catheterization in Portal Hypertensive Patients
  • A randomized trial comparing the uncovered to the covered wallstent in the palliation of malignant bile duct strictures

Bruce Sands

  • Identification of Susceptibility Genes in Inflammatory Bowel Disease

Peter Kelsey, MD

  • A prospective comparison of duodenoscope assisted cholangiopancreatoscopy (DACP) and endoscopic retrograde cholangiopancreatography (ERCP) to ERCP alone
  • Contact person: Dr. Brenna Bounds 617-724-1685